Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30379% above fair value
$15.71−0.15 (-0.95%)
Close on Nov 13, 2026Market cap $1.68BP/E –Yield –
Personalis profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Personalis's profit margin for the twelve months ending Sep 30, 2026 was -147.7%. For fiscal 2025 it was -116.7%, against -96.1% the year before. The highest annual figure on record is -38.5% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -116.7% | −20.6 |
| FY2024 | Dec 31, 2024 | -96.1% | +51.3 |
| FY2023 | Dec 31, 2023 | -147.4% | +26.8 |
| FY2022 | Dec 31, 2022 | -174.2% | −97.9 |
| FY2021 | Dec 31, 2021 | -76.3% | −23.8 |
| FY2020 | Dec 31, 2020 | -52.5% | −14.0 |
| FY2019 | Dec 31, 2019 | -38.5% | +14.2 |
| FY2018 | Dec 31, 2018 | -52.6% | +198.6 |
| FY2017 | Dec 31, 2017 | -251.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -132.1% | +17.3 |
| Q2 FY2026 | Jun 30, 2026 | -141.7% | −25.1 |
| Q1 FY2026 | Mar 31, 2026 | -194.1% | −117.7 |
| Q4 FY2025 | Dec 31, 2025 | -137.3% | −39.5 |
| Q3 FY2025 | Sep 30, 2025 | -149.4% | +2.7 |
| Q2 FY2025 | Jun 30, 2025 | -116.6% | −59.9 |
| Q1 FY2025 | Mar 31, 2025 | -76.4% | −10.0 |
| Q4 FY2024 | Dec 31, 2024 | -97.8% | +37.3 |
| Q3 FY2024 | Sep 30, 2024 | -152.0% | +7.4 |
| Q2 FY2024 | Jun 30, 2024 | -56.7% | +86.8 |
| Q1 FY2024 | Mar 31, 2024 | -66.4% | +85.5 |
| Q4 FY2023 | Dec 31, 2023 | -135.1% | +50.7 |
| Q3 FY2023 | Sep 30, 2023 | -159.5% | +18.8 |
| Q2 FY2023 | Jun 30, 2023 | -143.5% | +7.6 |
| Q1 FY2023 | Mar 31, 2023 | -152.0% | +33.3 |
| Q4 FY2022 | Dec 31, 2022 | -185.8% | −88.1 |
| Q3 FY2022 | Sep 30, 2022 | -178.3% | −98.9 |
| Q2 FY2022 | Jun 30, 2022 | -151.0% | −82.0 |
| Q1 FY2022 | Mar 31, 2022 | -185.3% | −125.9 |
| Q4 FY2021 | Dec 31, 2021 | -97.7% | −31.5 |
| Q3 FY2021 | Sep 30, 2021 | -79.4% | −31.2 |
| Q2 FY2021 | Jun 30, 2021 | -69.0% | −21.5 |
| Q1 FY2021 | Mar 31, 2021 | -59.4% | −11.7 |
| Q4 FY2020 | Dec 31, 2020 | -66.1% | −29.5 |
| Q3 FY2020 | Sep 30, 2020 | -48.2% | −8.0 |
| Q2 FY2020 | Jun 30, 2020 | -47.5% | −10.4 |
| Q1 FY2020 | Mar 31, 2020 | -47.7% | −7.3 |
| Q4 FY2019 | Dec 31, 2019 | -36.6% | −9.6 |
| Q3 FY2019 | Sep 30, 2019 | -40.1% | −8.9 |
| Q2 FY2019 | Jun 30, 2019 | -37.1% | +46.0 |
| Q1 FY2019 | Mar 31, 2019 | -40.4% | +88.7 |
| Q4 FY2018 | Dec 31, 2018 | -27.0% | – |
| Q3 FY2018 | Sep 30, 2018 | -31.2% | – |
| Q2 FY2018 | Jun 30, 2018 | -83.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -129.1% | – |
See a number that looks wrong?